TB-PACTS data platform Mission:
The TB-PACTS data platform is designed to catalyze and accelerate TB research by curating and standardizing tuberculosis (TB) clinical trial data and making this data publicly available to qualified researchers. These researchers can access and analyze data in aggregate, or filter and view individual patient-level data from seventeen clinical trials, including REMoxTB, RIFAQUIN and OFLUTUB. Additional trial data may be available in the future.
TB-PACTS data platform Partnership:
This initiative represents a collaborative partnership between the Special Programme for Research and Training in Tropical Diseases (TDR), the TB Alliance, St. George’s University of London, Case Western University, the British Medical Research Council and Critical Path Institute (C-Path).
This partnership continues to expand the scale of the TB-PACTS platform by engaging with other TB clinical data contributors to secure additional datasets.
TB-PACTS data platform Content and Access:
The TB–PACTS data platform will catalog contemporary (TB) clinical trial data sets and make these data sets available to qualified researchers. Approved researchers can access patient-level data from seventeen clinical trials, including REMoxTB, RIFAQUIN and OFLOTUB. Additional trial data is expected to be made available in the future.
For information on how to access the TB-PACTS data platform, visit the TB-PACTS Platform page on this website.
For more information on TB-PACTS or how your organization can contribute data, please contact:
Scientific Director , Critical Path to TB Drug Regimens